1
Home
Companies

ASLAN Pharmaceuticals

ASLAN Pharmaceuticals
Leadership team

Andrew Howden (Independent Chairman)

Robert E. Hoffman (Independent Non-Executive Director)

John Dixon (Member of Scientific Advisory Board)

Products/ Services
Biotechnology, Health Care, Medical, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Singapore, Central Region, Singapore
Established
2010
Company Registration
SEC CIK number: 0001722926
Traded as
NASDAQ:ASLN
Social Media
URL
aslanpharma.com
Overview
Location

Summary
History
Mission
Vision
Key Team
Recognition and Award
References
Summary
ASLAN Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for global markets in the field of immunology and oncology.
History

ASLAN Pharmaceuticals was founded in 2009. In 2016, the company obtained exclusive worldwide rights to develop and commercialize varlitinib from Bayer.

Mission
ASLAN’s mission is to develop and commercialize effective, innovative and accessible therapeutics that create value for patients, physicians, family and physicians.
Vision
ASLAN’s vision is to become a leading global player in the biopharmaceutical sector, to discover and develop groundbreaking therapies that will improve the lives of patients around the world.
Key Team

Peter Foley (Member of Scientific Advisory Board)

Mark Graham (Member of Scientific Advisory Board)

Jacob Thyssen (Member of Scientific Advisory Board)

Peter Sly (Member of Scientific Advisory Board)

Tim Hammond (Member of Scientific Advisory Board)

Lawrence F. Eichenfield (Chairman of Scientific Advisory Board)

Patrick G. Holt (Member of Scientific Advisory Board)

Carl Alan Jason Morton Firth (Founder, CEO & Executive Director)

Eric Simpson (Member of Scientific Advisory Board)

Melinda Jennifer Gooderham (Member of Scientific Advisory Board)

Neil Graham (Independent Director)

Kathleen M. Metters (Independent Director)

Recognition and Awards
ASLAN has received numerous awards, including the World Economic Forum Technology Pioneers, the 2017 PharmaCI Awards and the 2018 PharmaCI Awards Asia.
References

https://in.investing.com/equities/aslan-pharmaceuticals

https://www.crunchbase.com/organization/aslan-pharmaceuticals

aslanpharma.com

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

ASLAN Pharmaceuticals
Leadership team

Andrew Howden (Independent Chairman)

Robert E. Hoffman (Independent Non-Executive Director)

John Dixon (Member of Scientific Advisory Board)

Products/ Services
Biotechnology, Health Care, Medical, Pharmaceutical
Number of Employees
0 - 50
Headquarters
Singapore, Central Region, Singapore
Established
2010
Company Registration
SEC CIK number: 0001722926
Traded as
NASDAQ:ASLN
Social Media
URL
aslanpharma.com